Kris Bryant Odds for 2025
Kris Bryant
Colorado Rockies
Loading Possible Bets...
Not expected back in 2025
Bryant (back) isn't expected to return from the 60-day injured list this season, Patrick Saunders of The Denver Post reports.
Analysis
Bryant played in 11 of the Rockies' first 14 games of the season, but a degenerative disc issue in his back has sidelined him ever since. According to MLB.com, Bryant consulted with a doctor in New York and a specialist in Dallas last month in an effort to explore non-surgical treatment plans for the back problem, as a fusion surgery would provide more relief for the 33-year-old but would make it difficult for him to continue his playing career. It's unclear what path Bryant will choose for treatment, but his 2025 season appears to be over after he slashed a miserable .154/.195/.205 with two doubles, one RBI, two runs scored and a 2:13 BB:K across 41 plate appearances. Since signing a seven-year, $182 million deal ahead of the 2022 season, Bryant has played in just 170 games for Colorado, registering a .244/.324/.370 slash line with 17 home runs, 61 RBI and 75 runs over 712 plate appearances.
Bryant played in 11 of the Rockies' first 14 games of the season, but a degenerative disc issue in his back has sidelined him ever since. According to MLB.com, Bryant consulted with a doctor in New York and a specialist in Dallas last month in an effort to explore non-surgical treatment plans for the back problem, as a fusion surgery would provide more relief for the 33-year-old but would make it difficult for him to continue his playing career. It's unclear what path Bryant will choose for treatment, but his 2025 season appears to be over after he slashed a miserable .154/.195/.205 with two doubles, one RBI, two runs scored and a 2:13 BB:K across 41 plate appearances. Since signing a seven-year, $182 million deal ahead of the 2022 season, Bryant has played in just 170 games for Colorado, registering a .244/.324/.370 slash line with 17 home runs, 61 RBI and 75 runs over 712 plate appearances.